-
Product Insights
New![]()
Onca Puma Mine
The Onca Puma Mine is a nickel mine in Brazil. It is currently in operation. Empower your strategies with our Onca Puma Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...
-
Product Insights
New![]()
Puma Station Solar PV Park
Puma Station Solar PV Park is a solar PV project located in Puerto Rico. The project is owned and developed by Pash Global; Puma Energy Holding Pte Ltd. The project is currently under construction. Empower your strategies with our Puma Station Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Company Insights
New![]()
Innovation and Patenting activity of Puma SE Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Puma SE Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
![]()
El Puma (Campo Indio Este – El Cerrito) Field, Argentina
El Puma (Campo Indio Este - El Cerrito) upstream field is located in Salta Province, Argentina. The upstream field is owned by Compania General de Combustibles SA. It is operated by Compania General de Combustibles SA. The project started its operations in 2019. El Puma (Campo Indio Este - El Cerrito) Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key...
-
Sector Analysis
New![]()
Middle East and Africa (MEA) Apparel Market Overview and Trend Analysis by Category and Forecasts to 2027
MEA Apparel Market Report Overview        The MEA apparel market size was valued at $64.9 billion in 2022. The MEA apparel market will grow at a CAGR of more than 3% during 2022-2027. The MEA apparel market report offers data showing the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share in 2022 in each of the sectors as well as total apparel. Middle East and Africa (MEA) Apparel Market Outlook...
-
Sector Analysis
New![]()
Apparel, Clothing and Accessories Sports Sponsorship Landscape – Analysing Key Brands and Spenders, Venue Rights, Deals and Case Studies
Apparel, Clothing, and Accessories Sports Sponsorship Landscape Report Overview The apparel, clothing, and accessories sector has an annual spend of $5.98 billion in sports sponsorship for 2023. Nike and Adidas stand as the pioneers in the realm of sports sponsorship from the clothing & accessories sector, strategically aligning with popular sports entities to elevate customer preference and expand their global market presence. At present EMEA region-based firms account for most of the sector’s expenditure. The apparel, clothing, and accessories sports sponsorship landscape...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EVX-301 in Psychiatric Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.EVX-301 in Psychiatric DisordersDrug Details:EVX-301 is under development for the treatment of acute suicidal ideation and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BAY-3018250 in Acute Ischemic Stroke
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BAY-3018250 in Acute Ischemic Stroke Drug Details: BAY-3018250 is under development for the treatment...
-
Sector Analysis
New![]()
Major European Soccer Kit Suppliers 2023-24 – Analyzing Sponsorship Deals, League and Brand/Partner Breakdown
GlobalData explores a comparable overview and analysis to the kit supplier market in European soccer for the 2023-24 season. This is a continued report theme, which offers great comparison to how the commercial landscape, for what is one of the biggest sponsorship contracts available to clubs, continues to evolve. The report takes a closer look at the landscape at all ten leading leagues individually before going into comparison, as to how they stack up against other major European leagues. The...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AUR-105 in Non-Hodgkin Lymphoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AUR-105 in Non-Hodgkin Lymphoma Drug Details:AUR-105 is under development for the treatment of solid tumor, non...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PB-357 in Breast Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.PB-357 in Breast CancerDrug Details:PB-357 is under development for the treatment of breast cancer. The drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Golimumab biosimilar in Psoriatic Arthritis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Golimumab biosimilar in Psoriatic Arthritis Drug Details: Golimumab biosimilar (BAT-2506) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – WCK-6777 in Pyelonephritis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. WCK-6777 in Pyelonephritis Drug Details: WCK-6777 is under development for the treatment of complicated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NFX-179 in Neurofibromatoses Type I (Von Recklinghausen’s Disease)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NFX-179 in Neurofibromatoses Type I (Von Recklinghausen’s Disease) Drug Details: NFX-179 is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HBM-1020 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. HBM-1020 in Solid Tumor Drug Details: HBM-1020 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TLL-041 in Amyotrophic Lateral Sclerosis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TLL-041 in Amyotrophic Lateral Sclerosis Drug Details: BHV-8000 (TLL-041) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-764532 in Neuroendocrine Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-764532 in Neuroendocrine Carcinoma Drug Details: OBT-620 is under development for the treatment of delta-like...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XmAb-306 in Refractory Multiple Myeloma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XmAb-306 in Refractory Multiple Myeloma Drug Details:XmAb-24306 is under development for the treatment of locally advanced...
-
Sector Analysis
![]()
Business of the Serie A 2023-24 – Property Profile, Sponsorship and Media Landscape
Business of Serie A Report Overview The Business of Serie A is estimated to generate an annual sponsorship revenue of $69.35 million for the 2023/24 season. Serie A is Italy’s highest division of professional soccer and forms part of the ‘big five’ leagues contested in Europe. The current league structure sees 20 clubs competing against each other twice, once at home and once away, with the top four clubs at the end of the Serie A season qualifying for the...
-
Sector Analysis
New![]()
Apparel Market Overview and Trend Analysis by Category and Forecasts to 2027
Apparel Market Report Overview       The apparel market size was valued at $2,005 billion in 2022. The apparel market will grow at a CAGR of more than 4% during 2022-2027. The apparel market report offers data showing the trends in the market and sectors by value and volume. It also reveals the brand leaders by market share in 2022 in each of the sectors as well as total apparel.  Apparel Market Outlook 2022-2027 ($ Billion) Buy the Full Report for More...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.